Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled Trial

BACKGROUND: Killed oral cholera vaccines (OCVs) have been licensed for use in developing countries, but protection conferred by licensed OCVs beyond two years of follow-up has not been demonstrated in randomized, clinical trials. METHODS/PRINCIPAL FINDINGS: We conducted a cluster-randomized, placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sur, Dipika, Kanungo, Suman, Sah, Binod, Manna, Byomkesh, Ali, Mohammad, Paisley, Allison M., Niyogi, Swapan K., Park, Jin Kyung, Sarkar, Banawarilal, Puri, Mahesh K., Kim, Deok Ryun, Deen, Jacqueline L., Holmgren, Jan, Carbis, Rodney, Rao, Raman, Thu Van, Nguyen, Han, Seung Hyun, Attridge, Stephen, Donner, Allan, Ganguly, Nirmal K., Bhattacharya, Sujit K., Nair, G. Balakrish, Clemens, John D., Lopez, Anna Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196468/
https://www.ncbi.nlm.nih.gov/pubmed/22028938
http://dx.doi.org/10.1371/journal.pntd.0001289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196468/
https://www.ncbi.nlm.nih.gov/pubmed/22028938
http://dx.doi.org/10.1371/journal.pntd.0001289

Ejemplares similares